Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases

ANZ Journal of Surgery

Volumn 83, Issue 11, 2013, Pages 847-852

  Cheung, Tan To ^a   Poon, Ronnie T P ^a,b   Yuen, Wai Key ^a   Chok, Kenneth S H ^a   Tsang, Simon H Y ^a   Yau, Thomas ^a   Chan, See Ching ^a,b   Lo, Chung Mau ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Colorectal cancer; Laparoscopic liver resection; Long term outcome; Survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL CANCER; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LAPAROSCOPIC LIVER RESECTION; LAPAROSCOPY; LENGTH OF STAY; LIVER RESECTION; LIVER TUMOR; LONG-TERM OUTCOME; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME;

COLORECTAL CANCER; LAPAROSCOPIC LIVER RESECTION; LONG-TERM OUTCOME; SURVIVAL ANALYSIS;

ADULT; AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LAPAROSCOPY; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84886787491     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2012.06270.x     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
2. Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann. Surg. Oncol. 2005; 12: 637-645.
3. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br. J. Cancer 2006; 94: 982-999.
4. Katkhouda N, Hurwitz MB, Rivera RT etal. Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann. Surg. 1998; 228: 568-578.
5. Brunt LM, Lairmore TC, Doherty GM, Quasebarth MA, DeBenedetti M, Moley JF. Adrenalectomy for familial pheochromocytoma in the laparoscopic era. Ann. Surg. 2002; 235: 713-720.
6. Hewett PJ, Allardyce RA, Bagshaw PF etal. Short-term outcomes of the Australasian randomized clinical study comparing laparoscopic and conventional open surgical treatments for colon cancer: the ALCCaS trial. Ann. Surg. 2008; 248: 728-738.
7. Lacy AM, Delgado S, Castells A, Pera M, Garcia-Valdecasas JC, Pique JM. Laparoscopic assisted colectomy (LAC) for colon cancer: results of a randomized controlled trial. Gastroenterology 2001; 120: A35.
8. Cheung TT, Ng KK, Poon RT, Chan SC, Lo CM, Fan ST. A case of laparoscopic hepatectomy for recurrent hepatocellular carcinoma. World J. Gastroenterol. 2010; 16: 526-530.
9. Fan ST, Lo CM, Poon RT etal. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann. Surg. 2011; 253: 745-758.
10. Pang YY. The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2: 333-339. HPB (Oxford) 2002; 4: 99-100.
11. Yau T, Chan P, Ching CY, Wong BC, Liang R, Epstein RJ. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies. Aliment. Pharmacol. Ther. 2008; 27: 997-1005.
12. Jaeck D, Bachellier P, Guiguet M etal. Long-term survival following resection of colorectal hepatic metastases. Br. J. Surg. 1997; 84: 977-980.
13. Koopman M, Venderbosch S, Nagtegaal ID, van Krieken JH, Punt CJ. A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? Eur. J. Cancer 2009; 45: 1935-1949.
14. Sanoff HK, Sargent DJ, Campbell ME etal. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J. Clin. Oncol. 2008; 26: 5721-5727.
15. Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J. Clin. Oncol. 2004; 22: 1209-1214.
16. Grothey A, De Gramont A, Sargent D. Strength of association between 3 year (Yr) disease free survival (Dfs) and overall survival (Os) differs between stage II/III colon cancer: updated findings from 20, 898 patient (Pt) ACCENT dataset. Ann. Oncol. 2009; 20: 16.
17. Adam R, Delvart V, Pascal G etal. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy - a model to predict long-term survival. Ann. Surg. 2004; 240: 644-657.
18. Adam R, Delvart V, Pascal G etal. Resection of nonresectable liver metastases after chemotherapy: prognostic factors and long-term results. J. Clin. Oncol. 2004; 22: 257S.
19. Rubie C, Frick VO, Ghadjar P etal. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. World J. Gastroenterol. 2011; 17: 3109-3116.
20. Eadens MJ, Grothey A. Curable metastatic colorectal cancer. Curr. Oncol. Rep. 2011; 13: 168-176.
21. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Steatohepatitis as a potential risk factor for major hepatic resection. Gastroenterology 1997; 112: A1430.
22. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy - a matched case-control study. Ann. Surg. 2007; 245: 923-930.
23. Kooby DA, Fong Y, Suriawinata A etal. Impact of steatosis on perioperative outcome following hepatic resection. J. Gastrointest. Surg. 2003; 7: 1034-1043.
24. Gomez D, Malik HZ, Bonney GK etal. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br. J. Surg. 2007; 94: 1395-1402.
25. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J. Am. Coll. Surg. 2005; 200: 845-853.
26. Vauthey JN, Dixon E, Abdalla EK etal. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB 2010; 12: 289-299.
27. Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg. Laparosc. Endosc. 1991; 1: 144-150.
28. Laurent C, Leblanc F, Wutrich P, Scheffler M, Rullier E. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results. Ann. Surg. 2009; 250: 54-61.
29. Law WL, Chu KW, Tung PH. Laparoscopic colorectal resection: a safe option for elderly patients. J. Am. Coll. Surg. 2002; 195: 768-773.
30. Chapman AE, Levitt MD, Hewett P, Woods R, Sheiner H, Maddern GJ. Laparoscopic-assisted resection of colorectal malignancies: a systematic review. Ann. Surg. 2001; 234: 590-606.
31. Simillis C, Constantinides VA, Tekkis PP etal. Laparoscopic versus open hepatic resections for benign and malignant neoplasms - a meta-analysis. Surgery 2007; 141: 203-211.
32. Kaneko H, Otsuka Y, Takagi S, Tsuchiya M, Tamura A, Shiba T. Hepatic resection using stapling devices. Am. J. Surg. 2004; 187: 280-284.
33. Chang S, Laurent A, Tayar C, Karoui M, Cherqui D. Laparoscopy as a routine approach for left lateral sectionectomy. Br. J. Surg. 2007; 94: 58-63.
34. Dagher I, Belli G, Fantini C etal. Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience. J. Am. Coll. Surg. 2010; 211: 16-23.
35. Sasaki A, Nitta H, Otsuka K, Takahara T, Nishizuka S, Wakabayashi G. Ten-year experience of totally laparoscopic liver resection in a single institution. Br. J. Surg. 2009; 96: 274-279.
36. Nguyen KT, Laurent A, Dagher I etal. Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Ann. Surg. 2009; 250: 842-848.